2-(异喹啉-3-基)乙腈 | 58130-44-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 2-(异喹啉-3-基)乙腈
• 英文名称: 2-(isoquinolin-3-yl)acetonitrile
• 英文别名: 2-isoquinolin-3-ylacetonitrile
• CAS: 58130-44-2
• 化学式: C₁₁H₈N₂
• 分子量: 168.198
• InChiKey: CKCLOSHFYMUHSU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  36.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(异喹啉-3-基)乙腈 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 、 sodium hydroxide 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.25h， 生成 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-[2-(isoquinolin-3-yl)acetamido]morphinan
  参考文献：
  名称：

  Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan analogues as opioid receptor ligands

  摘要：

  A series of 17-cyclopropylmethyl-3,14 beta-dihydroxy-4,5 alpha-epoxy-6 alpha-(isoquinoline-3 '-carboxamido)morphinan (NAQ) analogues were synthesized and pharmacologically characterized to study their structure-activity relationship at the mu opioid receptor (MOR). The competition binding assay showed two-atom spacer and aromatic side chain were optimal for MOR selectivity. Meanwhile, substitutions at the 1 '- and/or 4 '-position of the isoquinoline ring retained or improved MOR selectivity over the kappa opioid receptor while still possessing above 20-fold MOR selectivity over the delta opioid receptor. In contrast, substitutions at the 6 '- and/or 7 '-position of the isoquinoline ring reduced MOR selectivity as well as MOR efficacy. Among this series of ligands, compound 11 acted as an antagonist when challenged with morphine in warm-water tail immersion assay and produced less significant withdrawal symptoms compared to naltrexone in morphine-pelleted mice. Compound 11 also antagonized the intracellular Ca2+ increase induced by DAMGO. Molecular dynamics simulation studies of 11 in three opioid receptors indicated orientation of the 6 '-nitro group varied significantly in the different 'address' domains of the receptors and played a crucial role in the observed binding affinities and selectivity. Collectively, the current findings provide valuable insights for future development of NAQ-based MOR selective ligands. Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmc.2015.02.055
• 作为产物：
  描述：

  3-甲基异喹啉 在 四氯化碳 、 N-溴代丁二酰亚胺(NBS) 、 乙醇 、 过氧化苯甲酰 作用下， 生成 2-(异喹啉-3-基)乙腈
  参考文献：
  名称：

  噻唑和异喹啉结构的比较研究

  摘要：

  为了检验噻唑和异喹啉环在结构上的相似性的想法（可以追溯到Mills和Bmith），详细研究了4-甲基噻唑和3-甲基异喹啉对苯甲醛的行为。已经发现在两种情况下都发生缩合，但是在噻唑衍生物的情况下，这主要产生苯基-[4-甲基噻唑基-（2）]甲醇，而3-苯乙烯基邻苯二酚喹啉在相当的条件下由异喹啉衍生物形成。通过合成验证了这些化合物的结构。

  DOI：

  10.1002/hlca.19480310715

文献信息

• QUINOLINYL AND BENZOTHIAZOLYL MODULATORS
  申请人：——

  公开号：US20020169185A1

  公开（公告）日：2002-11-14

  Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPAR&ggr;. In particular, the compounds of the invention modulate the function of PPAR&ggr;. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

  本发明提供有用于治疗或预防由PPAR&ggr;介导的疾病或疾病的化合物、组合物和方法。特别地，本发明的化合物调节PPAR&ggr;的功能。该方法特别适用于治疗和/或预防糖尿病、肥胖症、高胆固醇血症、类风湿性关节炎和动脉粥样硬化。
• Quinolinyl and benzothiazolyl modulators
  申请人：Tularik Inc.

  公开号：US20030171399A1

  公开（公告）日：2003-09-11

  Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPAR&ggr;. In particular, the compounds of the invention modulate the function of PPAR&ggr;. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

  本发明提供了一些化合物、组合物和方法，这些化合物、组合物和方法对于治疗或预防由PPAR&ggr;介导的疾病或疾患非常有用。特别地，本发明的化合物调节PPAR&ggr;的功能。这些方法特别适用于治疗和/或预防糖尿病、肥胖症、高胆固醇血症、类风湿性关节炎和动脉粥样硬化。
• POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS
  申请人：Luo Steven

  公开号：US20090099325A1

  公开（公告）日：2009-04-16

  A method for preparing a functionalized polymer, the method comprising the steps of preparing a reactive polymer and reacting the reactive polymer with a heterocyclic nitrile compound.

  一种制备功能化聚合物的方法，包括以下步骤：制备一种反应性聚合物，并将该反应性聚合物与杂环腈化合物反应。
• Process for producing functionalized polymers
  申请人：BRIDGESTONE CORPORATION

  公开号：US10370460B1

  公开（公告）日：2019-08-06

  A method for producing a functionalized polymer, the method comprising the steps of: (i) preparing a bulk polymerization system including a reactive polymer by introducing a lanthanide-based catalyst and a conjugated diene monomer; (ii) adding a heterocyclic nitrile compound the polymerization system including the reactive polymer to prepare polymerization system including a functionalized polymer; and (iii) adding a protic compound to the polymerization system including a functionalized polymer where the ratio of water or protic hydrogen atoms in the protic compound to the lanthanide atoms in the lanthanide-based catalyst is at least 1500 to 1.

  一种生产官能化聚合物的方法，该方法包括以下步骤(i) 通过引入镧系催化剂和共轭二烯单体，制备包括反应性聚合物的大块聚合体系； (ii) 向包括反应性聚合物的聚合体系中加入杂环腈化合物，制备包括官能化聚合物的聚合体系； 以及 (iii) 向包括官能化聚合物的聚合体系中加入原生化合物，其中原生化合物中的水或原生氢原子与镧系催化剂中的镧系原子之比至少为 1500 比 1。
• Polymers functionalized with heterocyclic nitrile compounds
  申请人：BRIDGESTONE CORPORATION

  公开号：US10550203B2

  公开（公告）日：2020-02-04

  A method for preparing a functionalized polymer, the method comprising the steps of preparing a reactive polymer and reacting the reactive polymer with a heterocyclic nitrile compound.

  一种制备官能化聚合物的方法，该方法包括以下步骤：制备反应性聚合物，并使反应性聚合物与杂环腈化合物反应。